PATENT CLAIM ANALYSIS

Application Number: 15875082
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "133100"]

Abstract:
The present disclosure relates generally to a protocol to treat or prevent diseases or conditions associated with pathological forms of amyloid beta (Aβ), including Alzheimer's disease. Enabled herein is a reagent for use in the treatment and prophylaxis of Aβ-associated pathological conditions.

Claim (Index 23):
The method of  claim 22  wherein the amino acid at position 50 is selected from the list consisting of alanine, arginine, asparagine, aspartic acid, cysteine, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, pyrrolysine and selenocysteine.

Metadata:
- Claim Count in Document: 164.0
- Percentile: 86.0
- Lexical Diversity: 1.17073
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14910172', '12724343', '12788116', '15397569', '11195207']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8082029118889703
- 35 USC 102 Novelty (BERT): 0.5879159975141818
- Combined Prediction Score: 0.7861742204514914
- Mean Citation Score: 389.569902
- Max Citation Score: 613.6486
- Similarity Product: 406.53314120643137

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test